Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MEX3A contributes to development and progression of glioma through regulating cell proliferation and cell migration and targeting CCL2
Chao Yang, Haoqiang Zhan, Yiqing Zhao, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Mex-3 RNA binding family member A (MEX3A)/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagy
Rixin Chen, Shui-Dan Xu, Minhua Deng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
MEX3A promotes the malignant progression of ovarian cancer by regulating intron retention in TIMELESS
Fangfang Li, Chen Zhao, Yuchao Diao, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 20
MEX3A Impairs DNA Mismatch Repair Signaling and Mediates Acquired Temozolomide Resistance in Glioblastoma
Tian Gan, Yan Wang, Manyi Xie, et al.
Cancer Research (2022) Vol. 82, Iss. 22, pp. 4234-4246
Open Access | Times Cited: 17
MEX3A promotes colorectal cancer migration, invasion and EMT via regulating the Wnt/β-catenin signaling pathway
Jiannan Xu, Songyao Chen, Tengfei Hao, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access | Times Cited: 3
MEX3A determines in vivo hepatocellular carcinoma progression and induces resistance to sorafenib in a Hippo-dependent way
Shiji Fang, Liyun Zheng, Xiaoxiao Chen, et al.
Hepatology International (2023) Vol. 17, Iss. 6, pp. 1500-1518
Open Access | Times Cited: 9
Identification of a Fibroblast-Related Prognostic Model in Glioma Based on Bioinformatics Methods
Haofuzi Zhang, Yutao Huang, Erwan Yang, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1598-1598
Open Access | Times Cited: 13
Decoding the Role of MDM2 as a Potential Ubiquitin E3 Ligase and Identifying the Therapeutic Efficiency of Alkaloids against MDM2 in Combating Glioblastoma
Sudhanshu Sharma, Pravir Kumar
ACS Omega (2023) Vol. 8, Iss. 5, pp. 5072-5087
Open Access | Times Cited: 7
Oncogenic Potential of the Dual-Function Protein MEX3A
Marcell Lederer, Simon Müller, Markus Glaß, et al.
Biology (2021) Vol. 10, Iss. 5, pp. 415-415
Open Access | Times Cited: 17
Ubiquitylation of RUNX3 by RNA-binding ubiquitin ligase MEX3C promotes tumorigenesis in lung adenocarcinoma
Zelai He, Huijun Zhang, Haibo Xiao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Targeting MEX3A attenuates metastasis of breast cancer via β-catenin signaling pathway inhibition
Yun Wang, Qian Liang, Kefeng Lei, et al.
Cancer Letters (2021) Vol. 521, pp. 50-63
Closed Access | Times Cited: 15
RNA-binding protein MEX3D promotes cervical carcinoma tumorigenesis by destabilizing TSC22D1 mRNA
Zhi‐Ming Zheng, Xiaojing Chen, Xiaoyun Cai, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 11
MEX3A promotes nasopharyngeal carcinoma progression via the miR-3163/SCIN axis by regulating NF-κB signaling pathway
Xinxin Xiang, Yong-liang Liu, Yi‐Fan Kang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 10
Recruitment mechanisms and therapeutic implications of tumor-associated macrophages in the glioma microenvironment
Xianzhe Zhou, Guishan Jin, Junwen Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
GDNF Promotes Astrocyte Abnormal Proliferation and Migration Through the GFRα1/RET/MAPK/pCREB/LOXL2 Signaling Axis
Miaomiao Wang, Xiao Han, Wei Zha, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 10, pp. 6321-6340
Closed Access | Times Cited: 9
METTL3-mediated HOTAIRM1 promotes vasculogenic mimicry icontributionsn glioma via regulating IGFBP2 expression
Zhangyi Wu, Nan Wei
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 5
MEX3A promotes angiogenesis in colorectal cancer via glycolysis
Yong Lu, Tienan Bi, Shenkang Zhou, et al.
Libyan Journal of Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 4
The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4
Wenhu Chen, Li-qiang Hu, Xuemei Lu, et al.
Breast Cancer Research and Treatment (2023) Vol. 201, Iss. 3, pp. 353-366
Open Access | Times Cited: 4
RNA-Binding Protein MEX3A Interacting with DVL3 Stabilizes Wnt/β-Catenin Signaling in Endometrial Carcinoma
Pusheng Yang, Panpan Zhang, Shu Zhang
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 592-592
Open Access | Times Cited: 6
RNA-binding protein MEX3A controls G1/S transition via regulating the RB/E2F pathway in clear cell renal cell carcinoma
Yuntan Qiu, Meng Meng, Chuanzhen Cao, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 27, pp. 241-255
Open Access | Times Cited: 8
MicroRNA-1269 is downregulated in glioblastoma and its maturation is regulated by long non-coding RNA SLC16A1 Antisense RNA 1
Zhibin Jin, Heyang Li, Yinbo Long, et al.
Bioengineered (2022) Vol. 13, Iss. 5, pp. 12749-12759
Open Access | Times Cited: 5
MEX3A knockdown inhibits the tumorigenesis of colorectal cancer via modulating CDK2 expression
Xin Zhou, Shaojie Li, Tiexiang Ma, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 7
Hsa_circ_0008133 contributes to lung cancer progression by promoting glycolysis metabolism through the miR‐760/MEX3A axis
Shuhong Kang, Yunfeng Ni, Ke Lan, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 5, pp. 3014-3025
Closed Access
MEX3A is a new diagnostic, independent prognostic biomarker and a promising therapeutic target in gliomas
Francesca Bufalieri, Daniele Armocida, Antonino Cucinotta, et al.
Research Square (Research Square) (2024)
Open Access
Comprhensive Pan-cancer Analysis of MEX3A Gene and Its Related Mechanism
Zhiwei Wang, Eryou Feng, Dasheng Lin, et al.
Research Square (Research Square) (2024)
Open Access
Mex3a promoter hypomethylation can be utilized to diagnose HBV-associated hepatocellular carcinoma: a randomized controlled trial
Jie-Ru Yang, Yu‐Xin Tian, J. Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top